Please use this identifier to cite or link to this item: http://hdl.handle.net/10397/80239
PIRA download icon_1.1View/Download Full Text
DC FieldValueLanguage
dc.contributorDepartment of Applied Biology and Chemical Technology-
dc.contributorSchool of Nursing-
dc.creatorYee, A-
dc.creatorTsui, NBY-
dc.creatorChang, YN-
dc.creatorAu, CSM-
dc.creatorFok, M-
dc.creatorLau, LT-
dc.creatorChung, T-
dc.creatorCheng, G-
dc.creatorKwan, RYC-
dc.creatorLeung, AYM-
dc.creatorLau, JYN-
dc.creatorDai, DLK-
dc.date.accessioned2019-01-30T09:14:23Z-
dc.date.available2019-01-30T09:14:23Z-
dc.identifier.issn1024-2708-
dc.identifier.urihttp://hdl.handle.net/10397/80239-
dc.language.isoenen_US
dc.publisherHong Kong Academy of Medicine Pressen_US
dc.rights© Hong Kong Academy of Medicine. CC BY-NC-ND 4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/)en_US
dc.rightsThe following publication Yee, A., Tsui, N.B.Y., Chang, Y.N., Au, C.S.M., Fok, M., Lau, L.T., ... & Dai, D.L.K. (2018). Alzheimer's disease : insights for risk evaluation and prevention in the Chinese population and the need for a comprehensive programme in Hong Kong/China. Hong Kong medical journal (香港醫學雜誌), 24 (5), 492-500 is available at https://dx.doi.org/10.12809/hkmj187244en_US
dc.titleAlzheimer's disease : insights for risk evaluation and prevention in the Chinese population and the need for a comprehensive programme in Hong Kong/Chinaen_US
dc.typeJournal/Magazine Articleen_US
dc.identifier.spage492-
dc.identifier.epage500-
dc.identifier.volume24-
dc.identifier.issue5-
dc.identifier.doi10.12809/hkmj187244-
dcterms.abstractWith the ageing of the global population, China is projected to be impacted significantly by the rising number of patients with Alzheimer's disease (AD). A cure for AD is not yet available, so society should be prepared for an increasing AD-related burden. In this review, we examine this impending problem and provide overviews on (a) the magnitude of the problem of AD in Hong Kong/China in the near future; (b) the genetic and lifestyle risk factors that contribute to AD; (c) current diagnostic approaches and the potential of newly discovered genetic biomarkers for early detection; (d) medications, non-pharmacological interventions, and possible preventive measures; and (e) the need for social and psychological care from the community. In Hong Kong, primary care and AD-related support for at-risk individuals, patients, and caregivers are inadequate. A joint effort from the medical community, government, universities, non-governmental organisations/charities, and industry should initiate the development of a long-term programme for AD. Finally, we outline recommendations for the relevant parties to consider.-
dcterms.accessRightsopen accessen_US
dcterms.bibliographicCitationHong Kong medical journal (香港醫學雜誌), Oct. 2018, v. 24, no. 5, p. 492-500-
dcterms.isPartOfHong Kong medical journal (香港醫學雜誌)ulr with online record (no issn)-
dcterms.issued2018-
dc.identifier.isiWOS:000448268400009-
dc.identifier.pmid30232267-
dc.description.validate201901 bcrc-
dc.description.oaVersion of Recorden_US
dc.identifier.FolderNumberOA_IR/PIRAen_US
dc.description.pubStatusPublisheden_US
Appears in Collections:Journal/Magazine Article
Files in This Item:
File Description SizeFormat 
Yee_Alzheimer_Risk_Chinese.pdf587.06 kBAdobe PDFView/Open
Open Access Information
Status open access
File Version Version of Record
Access
View full-text via PolyU eLinks SFX Query
Show simple item record

Page views

278
Last Week
0
Last month
Citations as of Mar 24, 2024

Downloads

202
Citations as of Mar 24, 2024

SCOPUSTM   
Citations

17
Citations as of Mar 28, 2024

WEB OF SCIENCETM
Citations

15
Last Week
0
Last month
Citations as of Mar 28, 2024

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.